Issues and updates: evaluating estrogen receptor-α, progesterone receptor and HER2 in breast cancer
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Issues and updates: evaluating estrogen receptor-α, progesterone receptor and HER2 in breast cancer
Authors
Keywords
-
Journal
MODERN PATHOLOGY
Volume 23, Issue S2, Pages S52-S59
Publisher
Springer Nature
Online
2010-05-03
DOI
10.1038/modpathol.2010.55
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Adjuvant targeted therapy in early breast cancer
- (2009) John Mackey et al. CANCER
- Stemming Resistance to HER-2 Targeted Therapy
- (2009) Philippe L. Bedard et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- Beyond Cytotoxic Chemotherapy for the First-Line Treatment of HER2-Negative, Hormone-Insensitive Metastatic Breast Cancer: Current Status and Future Opportunities
- (2008) Alison K. Conlin et al. Clinical Breast Cancer
- Adjuvant Trastuzumab Therapy for HER2-Positive Breast Cancer
- (2008) Mohammad Jahanzeb Clinical Breast Cancer
- Her2-positive breast cancer: Herceptin and beyond
- (2008) Windy Dean-Colomb et al. EUROPEAN JOURNAL OF CANCER
- Update of evidence in chemotherapy for breast cancer
- (2008) Hiroyasu Yamashiro et al. International Journal of Clinical Oncology
- Relationship Between Quantitative Estrogen and Progesterone Receptor Expression and Human Epidermal Growth Factor Receptor 2 (HER-2) Status With Recurrence in the Arimidex, Tamoxifen, Alone or in Combination Trial
- (2008) Mitch Dowsett et al. JOURNAL OF CLINICAL ONCOLOGY
- Chemoendocrine Compared With Endocrine Adjuvant Therapies for Node-Negative Breast Cancer: Predictive Value of Centrally Reviewed Expression of Estrogen and Progesterone Receptors—International Breast Cancer Study Group
- (2008) Giuseppe Viale et al. JOURNAL OF CLINICAL ONCOLOGY
- Estrogen- and Progesterone-Receptor Status in ECOG 2197: Comparison of Immunohistochemistry by Local and Central Laboratories and Quantitative Reverse Transcription Polymerase Chain Reaction by Central Laboratory
- (2008) Sunil S. Badve et al. JOURNAL OF CLINICAL ONCOLOGY
- Breast Cancer Testing Scandal Shines Spotlight on Black Box of Clinical Laboratory Testing
- (2008) K. Hede JNCI-Journal of the National Cancer Institute
- Current issues in ER and HER2 testing by IHC in breast cancer
- (2008) Allen M Gown MODERN PATHOLOGY
- Commentary: Hormone Receptor Testing in Breast Cancer: A Distress Signal from Canada
- (2008) D. C. Allred ONCOLOGIST
- Trastuzumab in the Adjuvant Treatment of Early-Stage Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
- (2008) I. J. Dahabreh et al. ONCOLOGIST
- Trastuzumab as adjuvant systemic therapy for HER2-positive breast cancer
- (2008) Gabriella Mariani et al. Nature clinical practice. Oncology
- The role of hormonal therapy in the management of hormonal-receptor-positive breast cancer with co-expression of HER2
- (2008) Aleix Prat et al. Nature clinical practice. Oncology
- Membrane-initiated steroid action in breast and prostate cancer
- (2007) M KAMPA et al. STEROIDS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search